Technovalia, Pty Ltd
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults (NCT05605470) | Technovalia, Pty Ltd | 2023-01-19 |
Track Technovalia, Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.